First human doses given for new metabolic disease drug
NCT ID NCT07417124
Summary
This is a very early study to check the safety and side effects of a new drug called SNS851, which is being developed for metabolic diseases. It will be given to 52 healthy volunteers to see how their bodies react to it. The main goal is to find out what doses are safe and how the drug moves through the body, not to treat any illness.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METABOLIC DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Veritus Research
RECRUITINGMelbourne, Australia
Conditions
Explore the condition pages connected to this study.